Back to top
more

Zoetis (ZTS)

(Delayed Data from NYSE)

$150.88 USD

150.88
3,640,343

+1.32 (0.88%)

Updated Apr 24, 2024 04:00 PM ET

After-Market: $150.87 -0.01 (-0.01%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value C Growth C Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 42% (147 out of 252)

Industry: Medical - Drugs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for ZTS

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

Fiscal Year End for Zoetis Inc falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 2,041 3,581 3,485 3,604 1,934
Receivables 1,304 1,215 1,133 1,013 1,086
Notes Receivable 0 0 0 0 0
Inventories 2,564 2,345 1,923 1,628 1,410
Other Current Assets 434 365 389 366 318
Total Current Assets 6,343 7,506 6,930 6,611 4,748
Net Property & Equipment 3,204 2,753 2,422 2,202 1,940
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 206 173 100 94 88
Intangibles 4,097 4,126 4,156 4,404 4,482
Deposits & Other Assets 206 147 111 106 98
Total Assets 14,286 14,925 13,900 13,609 11,545
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 0 0 0 0 0
Accounts Payable 411 405 436 457 301
Current Portion Long-Term Debt 3 1,352 0 604 500
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 1,065 982 1,102 851 819
Income Taxes Payable 110 157 38 46 36
Other Current Liabilities 300 271 221 212 150
Total Current Liabilities 1,889 3,167 1,797 2,170 1,806
Mortgages 0 0 0 0 0
Deferred Taxes/Income 146 142 320 378 434
Convertible Debt 0 0 0 0 0
Long-Term Debt 6,564 6,552 6,592 6,595 5,947
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 508 475 496 530 486
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 9,295 10,522 9,356 9,836 8,837
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 5 5 5 5 5
Capital Surplus 1,133 1,088 1,068 1,065 1,044
Retained Earnings 10,295 8,668 7,186 5,659 4,427
Other Equity -845 -819 -763 -726 -726
Treasury Stock 5,597 4,539 2,952 2,230 2,042
Total Shareholder's Equity 4,991 4,403 4,544 3,773 2,708
Total Liabilities & Shareholder's Equity 14,286 14,925 13,900 13,609 11,545
Total Common Equity 4,991 4,403 4,544 3,773 2,708
Shares Outstanding 459.10 466.00 473.10 475.20 476.30
Book Value Per Share 10.87 9.45 9.60 7.94 5.69

Fiscal Year End for Zoetis Inc falls in the month of December.

All items in Millions except Per Share data.

3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Assets          
Cash & Equivalents -99,999 2,041 1,754 1,717 2,109
Receivables NA 1,304 1,257 1,322 1,186
Notes Receivable NA 0 0 0 0
Inventories NA 2,564 2,744 2,701 2,563
Other Current Assets NA 434 467 443 411
Total Current Assets NA 6,343 6,222 6,183 6,269
Net Property & Equipment NA 3,204 3,092 3,011 2,913
Investments & Advances NA 0 0 0 0
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 206 190 192 161
Intangibles NA 4,097 4,160 3,966 4,052
Deposits & Other Assets NA 206 216 173 143
Total Assets NA 14,286 14,106 13,749 13,754
Liabilities & Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Notes Payable NA 0 0 0 0
Accounts Payable NA 411 388 464 424
Current Portion Long-Term Debt NA 3 2 2 3
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 1,065 977 936 933
Income Taxes Payable NA 110 144 87 277
Other Current Liabilities NA 300 97 280 278
Total Current Liabilities NA 1,889 1,608 1,769 1,915
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 146 160 121 131
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 6,564 6,552 6,555 6,559
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 521 495 478
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 9,295 9,032 9,128 9,263
Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 5 5 5 5
Capital Surplus NA 1,133 1,116 1,098 1,079
Retained Earnings NA 10,295 10,140 9,543 9,045
Other Equity NA -845 -818 -899 -831
Treasury Stock NA 5,597 5,369 5,126 4,807
Total Shareholder's Equity NA 4,991 5,074 4,621 4,491
Total Liabilities & Shareholder's Equity NA 14,286 14,106 13,749 13,754
Total Common Equity 0 4,991 5,074 4,621 4,491
Shares Outstanding 457.30 459.10 459.10 462.10 462.10
Book Value Per Share 0.00 10.87 11.05 10.00 9.72